Belano Medical Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
14
- Latest Deal Type
-
M&A
Belano Medical General Information
Description
Operator of a human microbiome research company intended to develop medical and skincare products. The company develops and markets novel therapeutic approaches for medical skin care, for the prevention of diseases and for supporting healing processes, enabling patients to get new therapy options for diseases and indications that have not been satisfactorily treated to date.
Contact Information
Website
www.belanomedical.comCorporate Office
- Neuendorfstraße 19
- 16761 Hennigsdorf
- Germany
Corporate Office
- Neuendorfstraße 19
- 16761 Hennigsdorf
- Germany
Belano Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 08-Apr-2024 | Completed | Generating Revenue | |||
| 2. Bankruptcy: Liquidation | 20-Feb-2024 | Completed | Bankruptcy: Liquidation | |||
| 1. Later Stage VC | 31-Aug-2020 | Completed | Generating Revenue |
Belano Medical Patents
Belano Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022180077-A1 | Agent for binding and displacing corona viruses on living cells and on surfaces | Inactive | 24-Feb-2021 | ||
| DE-102021000989-A1 | Means for binding and displacing corona viruses on living cells and surfaces | Pending | 24-Feb-2021 | ||
| DE-102019007892-A1 | New formulation of lactobacillus strains for the therapy and prophylaxis of the colonization with helicobacter pylori in the upper respiratory tract and digestive system | Pending | 14-Nov-2019 | ||
| EP-4058038-A1 | New formulation of lactobacillus strains for the treatment and prevention of heli-cobacter pylori colonisation in the upper airways and the digestive system | Inactive | 14-Nov-2019 | ||
| US-20220409680-A1 | New formulation of lactobacillus strains for the treatment and prevention of helicobacter pylori colonisation in the upper airways and the digestive system | Inactive | 14-Nov-2019 | A61K35/747 |
Belano Medical Signals
Belano Medical Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Deutsche Biotech Innovativ | Corporation | Minority | ||
| b.value | Venture Capital | Minority |
Belano Medical FAQs
-
When was Belano Medical founded?
Belano Medical was founded in 2010.
-
Where is Belano Medical headquartered?
Belano Medical is headquartered in Hennigsdorf, Germany.
-
What is the size of Belano Medical?
Belano Medical has 14 total employees.
-
What industry is Belano Medical in?
Belano Medical’s primary industry is Drug Discovery.
-
Is Belano Medical a private or public company?
Belano Medical is a Private company.
-
What is Belano Medical’s current revenue?
The current revenue for Belano Medical is .
-
Who are Belano Medical’s investors?
Deutsche Biotech Innovativ and b.value have invested in Belano Medical.
-
When was Belano Medical acquired?
Belano Medical was acquired on 08-Apr-2024.
-
Who acquired Belano Medical?
Belano Medical was acquired by Rigix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process